
Glucagon-like peptide-1 receptor agonists beneficial as add-on
(HealthDay)—Lixisenatide and glulisine as add-on to basal insulin result in a reduction in glycated hemoglobin (HbA1c) levels in patients with type 2 diabetes, according to a study published online June 22 in Diabetes Care.
Jul 1, 2016
0
3